bioAffinity Technologies, Inc. (BIAFW)
BIAFW Stock Price Chart
Explore bioAffinity Technologies, Inc. interactive price chart. Choose custom timeframes to analyze BIAFW price movements and trends.
BIAFW Company Profile
Discover essential business fundamentals and corporate details for bioAffinity Technologies, Inc. (BIAFW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Specialties
IPO Date
6 Mar 2026
Employees
57.00
Website
http://www.bioaffinitytech.comCEO
Maria Zannes
Description
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
BIAFW Financial Timeline
Browse a chronological timeline of bioAffinity Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 Aug 2026
EPS estimate is -$2.10, while revenue estimate is $1.70m.
Earnings released on 8 May 2026
EPS came in at -$0.81 surpassing the estimated -$2.40 by +66.25%, while revenue for the quarter reached $1.35m , missing expectations by -8.87%.
Earnings released on 13 Mar 2026
EPS came in at $5.98 surpassing the estimated -$2.70 by +321.48%, while revenue for the quarter reached $1.59m , beating expectations by +2.51%.
Earnings released on 14 Nov 2025
EPS came in at -$4.74 falling short of the estimated -$2.70 by -75.44%, while revenue for the quarter reached $1.45m , beating expectations by +2.49%.
Earnings released on 14 Aug 2025
EPS came in at -$0.17 surpassing the estimated -$3.00 by +94.37%, while revenue for the quarter reached $1.27m , missing expectations by -15.70%.
Earnings released on 15 May 2025
EPS came in at -$0.16 falling short of the estimated -$0.16 by -2.26%, while revenue for the quarter reached $1.85m , missing expectations by -12.09%.
Earnings released on 30 Sept 2023
EPS came in at -$0.00 , while revenue for the quarter reached $298.48k .
Earnings released on 30 Jun 2023
EPS came in at -$0.00 , while revenue for the quarter reached $19.74k .
Earnings released on 31 Mar 2023
EPS came in at -$0.00 , while revenue for the quarter reached $921.00 .
BIAFW Stock Performance
Access detailed BIAFW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
